Fundraising FoxExpansion Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Exobiosphereexobiosphere.cominApr 2025
Exobiosphere is building a standardized space-based high-throughput testing platform that lets pharma and biotech partners run automated experiments in orbit, using microgravity combined with lab automation and bioinformatics to create more physiologically relevant 3D biology models.
BiotechDeep TechSpace Tech
Kyle Acierno(Co-Founder & Chief Executive Officer)inBruno Santos(Co-Founder & Director of R&D)inOlivia Borgue(Co-Founder & Director of Engineering)in
PartnerTed Elvhage· solo GP
Co-investorsExpon Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.